Insmed INSM Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $819.56M+115% | $606.42M+66.7% | $447.02M+30.3% | $398.11M+21.2% | $381.03M+20.8% | ||
| $149.08M+66.5% | $122.94M+43.4% | $104.87M+34.4% | $96.67M+31.4% | $89.56M+29.4% | ||
| $828M+31.5% | $771.09M+28.9% | $695.91M+25.2% | $660.3M+28.5% | $629.86M+11.6% | ||
| $800.88M+55.3% | $701.17M+52.1% | $631.2M+56.0% | $563.75M+51.6% | $515.56M+46.7% | ||
| $1.97B+44.8% | $1.85B+49.2% | $1.6B+37.2% | $1.4B+28.8% | $1.36B+33.2% | ||
| -$1.15B-17.4% | -$1.25B-42.0% | -$1.16B-40.1% | -$1B-32.2% | -$980.89M-38.7% | ||
| -140.6%+117pp | -205.6%+35.9pp | -258.9%-18.0pp | -252.4%-21.0pp | -257.4%-33.3pp | ||
| $82.31M-3.7% | $83.8M-1.3% | $84.75M+0.7% | $85.42M+2.4% | $85.44M+3.3% | ||
| -$2.71M— | -$1.84M— | —— | —— | —— | ||
| -$1.18B-16.7% | -$1.27B-39.7% | -$1.18B-37.0% | -$1.03B-28.8% | -$1.01B-35.6% | ||
| $5.58M+38.4% | $5.03M+35.6% | $4.74M+37.9% | $4.44M+49.4% | $4.03M+51.4% | ||
| -$1.18B-16.8% | -$1.28B-39.7% | -$1.18B-37.0% | -$1.03B-28.9% | -$1.01B-35.7% | ||
| -144.4%+121pp | -210.5%+40.7pp | -264.8%-12.8pp | -259.8%-15.5pp | -265.9%-29.2pp | ||
| -$5.74+3.2% | -$6.40-14.9% | -$6.17-11.2% | -$5.69-5.6% | -$5.93-13.4% | ||
| -$1.13B-16.9% | -$1.23B-41.9% | -$1.14B-40.1% | -$992.5M-32.0% | -$969.58M-38.5% | ||
| -138.3%+116pp | -202.9%+35.6pp | -255.9%-17.8pp | -249.3%-20.4pp | -254.5%-32.6pp | ||
| -$1.15B-17.4% | -$1.25B-42.0% | -$1.16B-40.1% | -$1B-32.2% | -$980.89M-38.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Insmed's revenue?
- Insmed (INSM) generated $819.6M in revenue over the trailing twelve months, up 115.1% year over year.
- Is Insmed profitable?
- Insmed is not currently profitable: it reported a net loss of $1.2B over the trailing twelve months, a -144.4% net margin.
- What are Insmed's profit margins?
- Gross margin is 81.8% and operating margin is -140.6%, with a -144.4% net margin.
- What is Insmed's earnings per share?
- Insmed's diluted EPS over the trailing twelve months is $-5.74.
- Where does Insmed's income statement data come from?
- Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
